<DOC>
	<DOCNO>NCT01722669</DOCNO>
	<brief_summary>The goal study evaluate much quercetin isoquercetin absorb single dose evaluate pharmacokinetic inhibition protein disulfide isomerase . Pharmacodynamic study also perform additional cohort 10 patient evidence antiphospholipid antibody</brief_summary>
	<brief_title>Quercetin PK/PD Study Healthy Adults Patients With Elevated Anti-phospholipid Antibodies</brief_title>
	<detailed_description>To compare absorption activity quercetin isoquercetin without ascorbic acid healthy adult . Oral chew contain quercetin ( 500mg ) isoquercetin ( 500 mg total ) without ascorbic acid give . Pharmacokinetic parameter ( AUC , Cmax , Tmax , elimination half-life ) determine 24 hour ( 8 time point ) . Pharmacodynamic inhibition protein disulfide isomerase activity also assess . In addition healthy subject , cohort 10 individual antiphospholipid antibody participate . These participant receive isoquercetin 1000 mg pharmacodynamics study perform time 0 4 hour . All study drug provide Quercegen Pharma .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<mesh_term>Quercetin</mesh_term>
	<criteria>Inclusion Criteria Subject willing participate provide inform consent Subject consider reliable capable adhere protocol per judgment Investigator Subjects group D must exhibit good organ reserve ( within prior 4 week ) define : 1 . Estimated GFR &gt; 35 ( formula ) , 2 . Platelet count &gt; 65 K/uL , 3 . Hemoglobin &gt; 10.5 grams/dL 4 . Total bilirubin &lt; 2.0 mg/dL Minimum age 18 year old Body mass index ( BMI ) 18 35 kg/m2 For cohort D ( antiphospholipid antibody ) . Subjects group D must least one positive antiphospholipid antibody within last 8 week and/or previous confirm antibody ( 2 occasion least 12 week apart ) : . Positive lupus anticoagulant ii . anticardiolipin antibody IgM IgG ( &gt; 40U GPL ) iii . antiÎ²2 Glycoprotein1 antibody titer ( &gt; 35 unit ) Exclusion Criteria Pregnant . If female childbearing age , negative urinary pregnancy test prior dose quercetin isoquercetin No history malabsorptive gastrointestinal disorder Currently take aspirin , NSAIDS , warfarin , lowmolecular weight heparin anticoagulant ( direct thrombin inhibitor factor X inhibitor ) . Note : Study subject take aspirin NSAIDS , treat physician concurs , permit enroll plan hold aspirin 10 day NSAIDS 24 hour prior dose quercetin/isoquercetin Prescribed niacin hyperlipidemia Known HIV History sensitivity intolerance flavonoid , niacin ascorbic acid May uncontrolled intercurrent illness include , limited ongoing active infection , hepatitis , symptomatic congestive heart failure , unstable angina pectoris cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>quercetin</keyword>
	<keyword>isoquercetin</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>